MyFinsight
Home
Blog
About
Cash and cash
equivalents
$1,708,318K
(53.39%↑ Y/Y)
Marketable debt securities
$1,599,829K
(-8.26%↓ Y/Y)
Accounts receivable, net
$912,739K
(60.95%↑ Y/Y)
Prepaid expenses and
other current assets
$302,176K
(105.12%↑ Y/Y)
Inventory
$97,110K
(35.46%↑ Y/Y)
Total current assets
$4,620,172K
(26.80%↑ Y/Y)
Property, plant and
equipment, net
$554,143K
(10.87%↑ Y/Y)
Operating lease
right-of-use assets
$183,359K
(-4.70%↓ Y/Y)
Deferred tax assets
$113,792K
(9.03%↑ Y/Y)
Other assets
$65,132K
(13.92%↑ Y/Y)
Restricted investments
$22,171K
(-67.68%↓ Y/Y)
Total assets
$5,558,769K
(21.74%↑ Y/Y)
Total liabilities and
stockholders' equity
$5,558,769K
(21.74%↑ Y/Y)
Total liabilities
$4,204,651K
(-2.57%↓ Y/Y)
Total stockholders'
equity
$1,354,118K
(440.37%↑ Y/Y)
Accumulated deficit
-$6,332,039K
(14.56%↑ Y/Y)
Accumulated other
comprehensive loss
-$32,138K
(-7.30%↓ Y/Y)
Total current
liabilities
$1,512,513K
(16.27%↑ Y/Y)
Liabilities related to the
sale of future...
$1,461,510K
Convertible debt
$1,010,981K
(-1.51%↓ Y/Y)
Operating lease
liabilities, net of current...
$210,495K
(-6.22%↓ Y/Y)
Other liabilities
$9,152K
(-16.28%↓ Y/Y)
Additional paid-in capital
$7,716,958K
(0.34%↑ Y/Y)
Common stock, 0.01 par
value per share,...
$1,337K
(2.06%↑ Y/Y)
Accrued expenses
$1,095,980K
(19.26%↑ Y/Y)
Liabilities related to the
sale of future...
$258,570K
Accounts payable
$108,016K
(5.49%↑ Y/Y)
Operating lease
liabilities
$45,933K
(-0.36%↓ Y/Y)
Deferred revenue
$4,014K
(-73.38%↓ Y/Y)
Back
Back
Balance Sheet
logo (21)-svg-svg
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
logo (21)-svg-svg
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
source: myfinsight.com